Literature DB >> 27063786

Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices.

Rita Báldi1, Dipanwita Ghosh2, Brad A Grueter2, Sachin Patel1,3.   

Abstract

Endocannabinoids (eCBs) are a class of bioactive lipids that mediate retrograde synaptic modulation at central and peripheral synapses. The highly lipophilic nature of eCBs and the pharmacological tools available to interrogate this system require unique methodological consideration, especially when applied to ex vivo systems such as electrophysiological analysis in acute brain slices. This unit provides protocols for measuring cannabinoid and eCB-mediated synaptic signaling in mouse brain slices, including analysis of short-term, long-term, and tonic eCB signaling modes, and the unique considerations for working with eCBs and TRPV1/cannabinoid ligands in acute brain slices.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  CB1 receptor; cannabinoid; electrophysiology; endocannabinoid; mouse

Mesh:

Substances:

Year:  2016        PMID: 27063786      PMCID: PMC4866814          DOI: 10.1002/cpns.8

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  54 in total

Review 1.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

2.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.

Authors:  G L Gerdeman; J Ronesi; D M Lovinger
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

3.  Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.

Authors:  Alexander F Hoffman; Murat Oz; Tara Caulder; Carl R Lupica
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

Review 4.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

5.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

6.  Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells.

Authors:  T A Pitler; B E Alger
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

Review 7.  Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.

Authors:  Benjamin F Cravatt; Aron H Lichtman
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

8.  Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus.

Authors:  David A Edwards; Longhua Zhang; Bradley E Alger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

9.  Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.

Authors:  Vivien Chevaleyre; Boris D Heifets; Pascal S Kaeser; Thomas C Südhof; Dominick P Purpura; Pablo E Castillo
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

10.  Coactivation of pre- and postsynaptic signaling mechanisms determines cell-specific spike-timing-dependent plasticity.

Authors:  Thanos Tzounopoulos; Maria E Rubio; John E Keen; Laurence O Trussell
Journal:  Neuron       Date:  2007-04-19       Impact factor: 17.173

View more
  2 in total

1.  Patch-clamp and multi-electrode array electrophysiological analysis in acute mouse brain slices.

Authors:  Kevin M Manz; Justin K Siemann; Douglas G McMahon; Brad A Grueter
Journal:  STAR Protoc       Date:  2021-04-05

2.  Histamine H3 Receptor Function Biases Excitatory Gain in the Nucleus Accumbens.

Authors:  Kevin M Manz; Jennifer C Becker; Carrie A Grueter; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2020-08-06       Impact factor: 13.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.